World Health Organization Releases First Guidelines on Weight Loss Medications

December 3, 2025 - 09:00

In a significant development, the World Health Organization (WHO) has unveiled its inaugural guidelines regarding the use of GLP-1 medications for weight loss. These guidelines aim to provide healthcare professionals with a framework for the safe and effective use of these drugs, which have gained popularity for their ability to assist in weight management.

GLP-1 medications, originally developed for diabetes treatment, have shown promising results in promoting weight loss among individuals with obesity. The WHO's guidelines emphasize the importance of a comprehensive approach to weight management, which includes lifestyle modifications such as diet and exercise in conjunction with medication.

Experts suggest that these guidelines could help standardize the use of GLP-1 medications globally, ensuring that patients receive appropriate care and support. The announcement marks a pivotal moment in the ongoing battle against obesity, as the WHO seeks to address this pressing public health issue through evidence-based recommendations.